Departments of1Neuroradiology.
2Neurosurgery, and.
J Neurosurg. 2020 Feb 7;134(3):761-770. doi: 10.3171/2019.11.JNS191845. Print 2021 Mar 1.
Current practice guidelines recommend delayed (≥ 3 months after operation) postoperative MRI after transsphenoidal surgery for pituitary adenomas, although this practice defers obtaining important information, such as the presence of a residual adenoma, that might influence patient management during the perioperative period. In this study, the authors compared detection of residual adenomas by means of early postoperative (EPO) MRI (< 48 hours postsurgery) with both surgeon intraoperative assessment and late postoperative (LPO) MRI at 3 months.
Adult patients who underwent microscopic transsphenoidal surgery for pituitary adenomas with MRI preoperatively, < 48 hours after the operation, 3 months postoperatively, and yearly for 4 years were included. The presence or absence of residual tumor was assessed intraoperatively by a single surgeon and postoperatively by 2 neuroradiologists blinded to the intraoperative assessment and other postoperative imaging studies. The presence of residual tumor was confirmed by reresection, tumor growth on imaging, or hormonal evidence. Interreader reliability was calculated at each imaging time point. Specificity, sensitivity, positive predictive value, and negative predictive value for EPO and LPO imaging and intraoperative assessment were determined.
In total, 102 consecutive patients who underwent microscopic transsphenoidal resection of a pituitary adenoma were included. Eighteen patients (18%) had confirmed residual tumors (12 confirmed by tumor growth, 5 by surgery, and 1 by biochemical evidence of persistent disease). Interreader reliability for detecting residual tumor on EPO MRI was almost perfect (κ = 0.88) and significantly higher than that for LPO MRI (κ = 0.69, p = 0.03). EPO MRI was highly specific for residual tumor (98%), a finding similar to that for intraoperative assessment (99%, p = 0.60) and significantly higher than that for LPO MRI (81%, p < 0.001). Notably, EPO MRI was significantly more sensitive for residual tumor (100%) than both intraoperative assessment (78%, p = 0.04) and LPO MRI (78%, p = 0.04). EPO MRI had a 100% negative predictive value and was used to find 4 residual tumors that were not identified intraoperatively. Residual tumors found on EPO MRI allowed for reresection during the same hospitalization for 3 patients.
EPO MRI after transsphenoidal pituitary surgery can be reliably interpreted and has greater sensitivity for detecting residual tumor than intraoperative assessment and LPO MRI. This result challenges current guidelines stating that delayed postoperative imaging is preferable to early imaging. Pituitary surgeons should consider performing EPO MRI either in addition to or instead of delayed imaging.
目前的实践指南建议在经蝶窦手术后进行延迟(术后 3 个月后)术后 MRI,尽管这种做法延迟了获得重要信息,例如残留腺瘤的存在,这可能会影响围手术期的患者管理。在这项研究中,作者比较了早期术后(EPO)MRI(术后<48 小时)与术中评估和术后 3 个月的晚期(LPO)MRI 检测残留腺瘤的情况。
纳入了接受显微镜下经蝶窦手术治疗垂体腺瘤的成年患者,术前、术后<48 小时、术后 3 个月以及术后 4 年每年进行 MRI 检查。由一位外科医生在术中进行评估,由两位神经放射科医生在术后进行评估,他们对术中评估和其他术后影像学研究均不知情。通过再次切除、影像学上肿瘤生长或激素证据来确认残留肿瘤的存在。在每个影像学时间点计算了读者间的可靠性。确定了 EPO 和 LPO 成像以及术中评估的特异性、敏感性、阳性预测值和阴性预测值。
共纳入了 102 例接受显微镜下经蝶窦切除术治疗垂体腺瘤的连续患者。18 例(18%)患者有确认的残留肿瘤(12 例通过肿瘤生长证实,5 例通过手术证实,1 例通过持续疾病的生化证据证实)。EPO MRI 检测残留肿瘤的读者间可靠性几乎是完美的(κ=0.88),明显高于 LPO MRI(κ=0.69,p=0.03)。EPO MRI 对残留肿瘤具有高度特异性(98%),这与术中评估(99%,p=0.60)相似,明显高于 LPO MRI(81%,p<0.001)。值得注意的是,EPO MRI 对残留肿瘤的敏感性(100%)明显高于术中评估(78%,p=0.04)和 LPO MRI(78%,p=0.04)。EPO MRI 的阴性预测值为 100%,并发现了 4 例术中未发现的残留肿瘤。EPO MRI 检测到的残留肿瘤使 3 名患者在同一住院期间进行了再次切除。
经蝶窦垂体手术后的 EPO MRI 可以可靠地进行解释,并且比术中评估和 LPO MRI 更敏感地检测到残留肿瘤。这一结果对目前主张延迟影像学检查优于早期影像学检查的指南提出了挑战。垂体外科医生应考虑进行 EPO MRI,既可作为延迟影像学检查的补充,也可替代延迟影像学检查。